TARGET-DERM: A Real-World Study of Patient-Reported Outcomes in Atopic Dermatitis

EP: 1.Quality of Life in Patients with Atopic Dermatitis and Patient-Reported Outcomes

EP: 2.Atopic Dermatitis Treatment Advances and Changing Quality of Life Expectations

EP: 3.Impact of JAK Inhibitors on Itch and Quality of Life in Atopic Dermatitis

Now Viewing

EP: 4.TARGET-DERM: A Real-World Study of Patient-Reported Outcomes in Atopic Dermatitis

EP: 5.Durability of Effect and Advice to Improve Quality of Life in Atopic Dermatitis

Video content above is prompted by the following questions:

• Can you discuss recently presented data from TARGET-DERM, a longitudinal, observational study, on the effect of skin severity and itch (both independent and combined) on patients’ QoL (RAD 2024 meeting)?
  • What do these data mean for clinicians?